Academic publishing is highly competitive, and this competition is only growing as more and more research papers are being submitted to top journals – submissions …
Roughly one year after dropping designs on a $200 million biologics plant in North Carolina, antibody-drug conjugate specialist Abzena has snared a fresh round of …
Drug development is an expensive, lengthy, and high-risk business taking 1015 years and is associated with a high attrition rate. Approximately only 1 in 10 …
Shiyan Caan of SQN Health examines the tools and services which provide the clinical trial market with the ability to adapt to a changing environment. …
Hadassah Medical Center, a leading healing, teaching, and research hospital in Jerusalem, Israel, is the first medical center in the country to join the TriNetX …
Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute …
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer (NSCLC), under a …
The new research centre is part of the company’s plans to strengthen investment in the R&D sector. Jeil Pharmaceutical has recently opened a new technology …
Pore-forming toxins are common bacterial poisons. They attack organisms by introducing holes in cell membranes. A team of scientists at the Technical University of Munich …
US government examines whether criteria for participating in drug studies unnecessarily exclude some people. Nearly 20% of publicly funded cancer clinical trials in the United …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
